Alteration of direct and indirect effects of cytomegalovirus

Nassim Kamar1, Catherine Mengelle, Lionel Rostaing

  • 1Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Insights

Cytomegalovirus infection in organ transplant recipients causes significant direct and indirect pathological effects. Prophylaxis is crucial for preventing these adverse outcomes, as pre-emptive therapy shows no long-term benefit for indirect effects.

Area of Science:

  • Immunology
  • Transplant Medicine
  • Virology

Background:

  • Cytomegalovirus (CMV) infection poses serious risks to solid organ transplant recipients due to potent immunosuppression.
  • CMV infection can lead to graft rejection, reduced survival, opportunistic infections, and malignancies.

Purpose of the Study:

  • To elucidate the direct and indirect pathological effects of cytomegalovirus infection in solid organ transplant recipients.
  • To evaluate the efficacy of prophylactic versus pre-emptive CMV therapy in mitigating these effects.

Main Methods:

  • Review of existing literature on CMV infection in transplant patients.
  • Analysis of direct effects (viral burden) and indirect effects (immune-mediated complications).

Main Results:

  • Direct effects include organ-specific injuries (e.g., cardiac allograft vasculopathy, BOS, VBD).
  • Indirect effects encompass posttransplant lymphoproliferative disorders, new-onset diabetes, and HCV recurrence.
  • Prophylaxis reduces both direct and indirect CMV effects, while pre-emptive therapy has limited long-term impact on indirect effects.

Conclusions:

  • Cytomegalovirus infection presents multifaceted challenges in solid organ transplantation.
  • Prophylactic strategies are essential for comprehensive prevention of CMV-related complications, particularly indirect effects.

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...